A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

NCT03000439 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis Juvenile Idiopathic

Interventions

DRUG: In open-label phase: treatment with tofacitinib
DRUG: In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio

Sponsor

Pfizer